• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Anterior migration of Ozurdex implant: a review on risk factors, complications, and management.Ozurdex植入物向前移位:关于危险因素、并发症及处理的综述
Int J Retina Vitreous. 2023 Nov 27;9(1):74. doi: 10.1186/s40942-023-00513-5.
2
Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report.地塞米松玻璃体内植入物前房脱位的处理:一例报告
J Med Case Rep. 2016 Oct 13;10(1):282. doi: 10.1186/s13256-016-1077-2.
3
The clinical outcomes of surgical management of anterior chamber migration of a dexamethasone implant (Ozurdex®).地塞米松植入物(Ozurdex®)前房移位的手术治疗临床结果
Graefes Arch Clin Exp Ophthalmol. 2017 Sep;255(9):1819-1825. doi: 10.1007/s00417-017-3705-y. Epub 2017 Jun 10.
4
Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies.地塞米松植入前房内迁移:危险因素、并发症和管理策略。
Ophthalmology. 2014 Jan;121(1):67-71. doi: 10.1016/j.ophtha.2013.06.033. Epub 2013 Jul 24.
5
[Anterior chamber migration of intravitreal dexamethasone implant (Ozurdex®) in pseudophakic eyes: report of three cases].[人工晶状体眼玻璃体内地塞米松植入物(Ozurdex®)前房迁移:三例报告]
J Fr Ophtalmol. 2013 Apr;36(4):362-7. doi: 10.1016/j.jfo.2012.11.003. Epub 2013 Jan 12.
6
Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex®) through basal iridectomy (Ando) in a pseudophakic patient.在一名人工晶状体眼患者中,地塞米松玻璃体内植入物(Ozurdex®)通过基底虹膜切除术(安藤术式)向前房迁移。
Eur J Ophthalmol. 2016 Apr 12;26(3):e52-4. doi: 10.5301/ejo.5000715.
7
Risk factors for and management of anterior chamber intravitreal dexamethasone implant migration.前房内玻璃体腔地塞米松植入物移位的危险因素及处理
BMC Ophthalmol. 2019 May 28;19(1):120. doi: 10.1186/s12886-019-1122-1.
8
Corneal toxicity after Ozurdex(®) migration into anterior chamber.Ozurdex(®)迁移至前房后的角膜毒性。
Arch Soc Esp Oftalmol. 2016 Jun;91(6):292-4. doi: 10.1016/j.oftal.2016.01.008. Epub 2016 Feb 24.
9
Anterior segment migration of intravitreal dexamethasone implant in a patient with scleral fixation intraocular lens implant: a case report.巩膜固定人工晶状体植入患者玻璃体内地塞米松植入物的前段移位:一例报告
J Surg Case Rep. 2024 Mar 8;2024(3):rjae121. doi: 10.1093/jscr/rjae121. eCollection 2024 Mar.
10
Anterior Chamber Dislocation of Dexamethasone Implant in the Presence of Carlevale Sutureless Scleral Fixation Intraocular Lens.在使用卡莱瓦尔无缝线巩膜固定人工晶状体的情况下地塞米松植入物的前房脱位
Case Rep Ophthalmol. 2023 May 23;14(1):229-233. doi: 10.1159/000529790. eCollection 2023 Jan-Dec.

引用本文的文献

1
Assessment the real-world safety of intravitreal dexamethasone implant (Ozurdex): novel insights from a comprehensive pharmacovigilance analysis utilizing the FAERS database.评估玻璃体内地塞米松植入剂(Ozurdex)的真实世界安全性:利用FAERS数据库进行全面药物警戒分析的新见解。
BMC Pharmacol Toxicol. 2025 Feb 10;26(1):29. doi: 10.1186/s40360-025-00866-7.
2
The Treatment of Diabetic Retinal Edema with Intravitreal Steroids: How and When.玻璃体内注射类固醇治疗糖尿病性视网膜水肿:方法与时机
J Clin Med. 2024 Feb 26;13(5):1327. doi: 10.3390/jcm13051327.

本文引用的文献

1
Anterior Chamber Dislocation of Dexamethasone Implant in the Presence of Carlevale Sutureless Scleral Fixation Intraocular Lens.在使用卡莱瓦尔无缝线巩膜固定人工晶状体的情况下地塞米松植入物的前房脱位
Case Rep Ophthalmol. 2023 May 23;14(1):229-233. doi: 10.1159/000529790. eCollection 2023 Jan-Dec.
2
Results of intravitreal dexamethasone implant (Ozurdex®) for retinal vascular diseases with macular edema: An observational study of real-life situations.玻璃体内注射地塞米松植入物(Ozurdex®)治疗伴有黄斑水肿的视网膜血管疾病的结果:真实情况的观察性研究。
Medicine (Baltimore). 2022 Jul 8;101(27):e29807. doi: 10.1097/MD.0000000000029807.
3
Active removal of anterior segment-migrated dexamethasone implant (Ozurdex).主动移除前段移位的地塞米松植入物(Ozurdex)。
GMS Ophthalmol Cases. 2022 Mar 22;12:Doc08. doi: 10.3205/oc000195. eCollection 2022.
4
Migration of a Dexamethasone Intravitreal Implant to the Anterior Chamber in a Patient with a Intra-Scleral Haptic Fixated Intraocular Lens.一名巩膜内襻固定人工晶状体患者的地塞米松玻璃体内植入物迁移至前房
Int Med Case Rep J. 2021 Sep 18;14:633-635. doi: 10.2147/IMCRJ.S327406. eCollection 2021.
5
Removal of a migrated dexamethasone implant (Ozurdex) from the anterior chamber using an intravenous cannula.使用静脉留置针从前房取出移位的地塞米松植入物(Ozurdex)。
BMJ Case Rep. 2021 Jul 9;14(7):e240504. doi: 10.1136/bcr-2020-240504.
6
Dexamethasone implant migration in an eye with congenital glaucoma: A case report and review of the literature.地塞米松植入物在先天性青光眼眼中的迁移:病例报告及文献复习。
Eur J Ophthalmol. 2022 Sep;32(5):NP46-NP50. doi: 10.1177/11206721211005696. Epub 2021 Mar 29.
7
Anterior Chamber Migration of Intravitreal Dexamethasone Implant in an Eye with Scleral-fixated Intraocular Lens.巩膜固定人工晶状体眼内玻璃体内地塞米松植入物的前房迁移
J Ophthalmic Vis Res. 2020 Oct 25;15(4):581-583. doi: 10.18502/jovr.v15i4.7798. eCollection 2020 Oct-Dec.
8
Complications of dexamethasone implants: risk factors, prevention, and clinical management.地塞米松植入物的并发症:危险因素、预防及临床管理
Int J Ophthalmol. 2020 Oct 18;13(10):1612-1620. doi: 10.18240/ijo.2020.10.16. eCollection 2020.
9
Anterior Chamber Migration of Ozurdex Implants.前房内奥扎格雷植入物的迁移。
Turk J Ophthalmol. 2020 Apr 29;50(2):115-122. doi: 10.4274/tjo.galenos.2019.43778.
10
Hole-in-one: simple non-surgical technique for the management of anterior chamber migrated Ozurdex implant.一杆进洞:用于处理前房内移位的Ozurdex植入物的简单非手术技术。
GMS Ophthalmol Cases. 2020 Feb 27;10:Doc05. doi: 10.3205/oc000132. eCollection 2020.

Ozurdex植入物向前移位:关于危险因素、并发症及处理的综述

Anterior migration of Ozurdex implant: a review on risk factors, complications, and management.

作者信息

Tsoutsanis Panagiotis, Kapantais Dimitrios

机构信息

Northern Care Alliance NHS Foundation Trust, Rochdale Eye Unit, Rochdale Infirmary, Greater Manchester, UK.

出版信息

Int J Retina Vitreous. 2023 Nov 27;9(1):74. doi: 10.1186/s40942-023-00513-5.

DOI:10.1186/s40942-023-00513-5
PMID:38012689
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10683211/
Abstract

PURPOSE

To describe the common risk factors, complications, and management options for anterior migration of Ozurdex implant.

METHODS

A comprehensive review of the literature was performed.

RESULTS

Amongst the most common risk factors predisposing to implant anterior migration we found a history of pseudophakia or aphakia or previous vitrectomy. The most common complication is that of corneal edema.

CONCLUSIONS

A variety of management options to treat migration of the dexamethasone implant are utilized by different specialists around the world. These depend on the doctor's preference, presence of corneal damage and history of previous migrations after repositioning the implant. The most common approaches are operative or non-operative implant repositioning and surgical implant removal.

摘要

目的

描述Ozurdex植入物向前移位的常见危险因素、并发症及处理方法。

方法

对文献进行全面综述。

结果

在导致植入物向前移位的最常见危险因素中,我们发现有假晶状体或无晶状体病史或既往玻璃体切除术史。最常见的并发症是角膜水肿。

结论

世界各地的不同专家采用了多种处理地塞米松植入物移位的方法。这些方法取决于医生的偏好、角膜损伤情况以及植入物重新定位后既往移位的病史。最常见的方法是手术或非手术方式重新定位植入物以及手术取出植入物。